CJC-1295 + Ipamorelin

The ultimate growth hormone stack for research. CJC-1295 is a growth hormone releasing hormone (GHRH) analog that stimulates HGH release, while Ipamorelin is a selective ghrelin receptor agonist. Together they create a synergistic effect for enhanced research outcomes.

10mg

Vial Size

99%+

Purity

5+2mg

Ratio

$65.00 $85.00 Save 24%

Synergistic GH release mechanism
Minimal side effect profile in studies
Growth hormone pulse mimicking
Batch certificate of analysis included

Back to Products

Comprehensive CJC-1295 + Ipamorelin Guide

The ultimate growth hormone stack for research applications

Synergistic Stack Mechanism

CJC-1295 (GHRH Analog)

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to release growth hormone. It has a long half-life, allowing for sustained GH elevation.

Long half-life (~7-10 days)
Sustained GH release
Increases IGF-1 levels

Ipamorelin (GHRP)

Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that stimulates GH release through the ghrelin receptor. It is known for its clean mechanism with minimal side effects.

Selective GHRP action
Minimal cortisol elevation
Does not affect prolactin

Research Use Only: This product is intended exclusively for laboratory research purposes. Not for human consumption. All research must be conducted in controlled laboratory settings by qualified personnel in accordance with applicable laws and regulations.

Growth Stack

3rd Party Tested

99%+ Purity

GHRP Stack - Synergistic Combination